Condition
RASopathy
Total Trials
7
Recruiting
7
Active
7
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 7 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Recruiting7
Clinical Trials (7)
Showing 7 of 7 trials
NCT04888936Recruiting
Clinical, Genetic, and Epidemiologic Study of Children and Adults With RASopathies
NCT07344480Recruiting
Retrospective Natural History Study of RASopathy-associated Cardiomyopathy (RAS-CM)
NCT06355622Not ApplicableRecruitingPrimary
Prevalence and Characterization of Pain in RASopathies
NCT06776380RecruitingPrimary
Pubertal Development in Patients with RASopathies
NCT06489067RecruitingPrimary
Study of the Thyroid Function and Echostructural Morphology in Patients Affected With Rasopathies (ECORAS2023)
NCT05761314Not ApplicableRecruitingPrimary
Solid Tumors in RASopathies
NCT06331117Not ApplicableRecruitingPrimary
Effect of RAS/MAPK Pathway Hyperactivation on Growth' and Bone' Profile of the RASopathies
Showing all 7 trials